vs

Side-by-side financial comparison of Taysha Gene Therapies, Inc. (TSHA) and Unusual Machines, Inc. (UMAC). Click either name above to swap in a different company.

Taysha Gene Therapies, Inc. is the larger business by last-quarter revenue ($5.5M vs $4.9M, roughly 1.1× Unusual Machines, Inc.). Unusual Machines, Inc. runs the higher net margin — -215.7% vs -507.8%, a 292.1% gap on every dollar of revenue. On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs 144.4%). Over the past eight quarters, Unusual Machines, Inc.'s revenue compounded faster (181.3% CAGR vs 26.8%).

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.

Thinking Machines Lab Inc. is an American artificial intelligence (AI) startup founded by Mira Murati, the former chief technology officer of OpenAI. The company was founded in February 2025, and by July had completed an early-stage funding round led by Andreessen Horowitz, raising $2 billion at a valuation of $12 billion overall from investors such as Nvidia, AMD, Cisco, and Jane Street. The company is based in San Francisco and structured as a public benefit corporation.

TSHA vs UMAC — Head-to-Head

Bigger by revenue
TSHA
TSHA
1.1× larger
TSHA
$5.5M
$4.9M
UMAC
Growing faster (revenue YoY)
TSHA
TSHA
+26.8% gap
TSHA
171.3%
144.4%
UMAC
Higher net margin
UMAC
UMAC
292.1% more per $
UMAC
-215.7%
-507.8%
TSHA
Faster 2-yr revenue CAGR
UMAC
UMAC
Annualised
UMAC
181.3%
26.8%
TSHA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TSHA
TSHA
UMAC
UMAC
Revenue
$5.5M
$4.9M
Net Profit
$-27.9M
$-10.6M
Gross Margin
36.2%
Operating Margin
-516.0%
-198.7%
Net Margin
-507.8%
-215.7%
Revenue YoY
171.3%
144.4%
Net Profit YoY
-48.3%
61.0%
EPS (diluted)
$-0.08
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TSHA
TSHA
UMAC
UMAC
Q4 25
$5.5M
$4.9M
Q3 25
$0
$2.1M
Q2 25
$2.0M
$2.1M
Q1 25
$2.3M
$2.0M
Q4 24
$2.0M
$2.0M
Q3 24
$1.8M
$1.5M
Q2 24
$1.1M
$1.4M
Q1 24
$3.4M
$618.9K
Net Profit
TSHA
TSHA
UMAC
UMAC
Q4 25
$-27.9M
$-10.6M
Q3 25
$-32.7M
$1.6M
Q2 25
$-26.9M
$-7.0M
Q1 25
$-21.5M
$-3.3M
Q4 24
$-18.8M
$-27.1M
Q3 24
$-25.5M
$-2.1M
Q2 24
$-20.9M
$-1.6M
Q1 24
$-24.1M
$-1.1M
Gross Margin
TSHA
TSHA
UMAC
UMAC
Q4 25
36.2%
Q3 25
39.4%
Q2 25
37.4%
Q1 25
24.3%
Q4 24
27.7%
Q3 24
26.1%
Q2 24
27.5%
Q1 24
33.0%
Operating Margin
TSHA
TSHA
UMAC
UMAC
Q4 25
-516.0%
-198.7%
Q3 25
-232.4%
Q2 25
-1347.1%
-338.5%
Q1 25
-930.5%
-160.0%
Q4 24
-985.8%
-642.3%
Q3 24
-1448.4%
-95.4%
Q2 24
-1915.4%
-111.4%
Q1 24
-713.3%
-175.5%
Net Margin
TSHA
TSHA
UMAC
UMAC
Q4 25
-507.8%
-215.7%
Q3 25
75.1%
Q2 25
-1353.6%
-327.9%
Q1 25
-935.2%
-159.9%
Q4 24
-929.0%
-1353.2%
Q3 24
-1427.5%
-140.0%
Q2 24
-1882.0%
-114.3%
Q1 24
-705.4%
-178.7%
EPS (diluted)
TSHA
TSHA
UMAC
UMAC
Q4 25
$-0.08
$-0.26
Q3 25
$-0.09
$0.05
Q2 25
$-0.09
$-0.32
Q1 25
$-0.08
$-0.21
Q4 24
$-0.07
$-3.20
Q3 24
$-0.10
$-0.30
Q2 24
$-0.09
$-0.16
Q1 24
$-0.10
$-0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TSHA
TSHA
UMAC
UMAC
Cash + ST InvestmentsLiquidity on hand
$319.8M
$142.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$246.9M
$174.9M
Total Assets
$343.3M
$182.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TSHA
TSHA
UMAC
UMAC
Q4 25
$319.8M
$142.5M
Q3 25
$297.3M
$81.1M
Q2 25
$312.8M
$38.9M
Q1 25
$116.6M
$5.0M
Q4 24
$139.0M
$3.8M
Q3 24
$157.7M
$1.7M
Q2 24
$172.7M
$2.2M
Q1 24
$124.0M
$3.2M
Stockholders' Equity
TSHA
TSHA
UMAC
UMAC
Q4 25
$246.9M
$174.9M
Q3 25
$219.0M
$106.0M
Q2 25
$248.7M
$51.3M
Q1 25
$55.1M
$15.9M
Q4 24
$71.5M
$14.8M
Q3 24
$88.8M
$19.2M
Q2 24
$108.9M
$20.0M
Q1 24
$53.8M
$21.2M
Total Assets
TSHA
TSHA
UMAC
UMAC
Q4 25
$343.3M
$182.7M
Q3 25
$316.6M
$113.1M
Q2 25
$333.3M
$52.4M
Q1 25
$138.4M
$17.3M
Q4 24
$160.4M
$16.1M
Q3 24
$180.2M
$24.5M
Q2 24
$200.4M
$25.2M
Q1 24
$153.0M
$24.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TSHA
TSHA
UMAC
UMAC
Operating Cash FlowLast quarter
$-26.7M
$-9.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TSHA
TSHA
UMAC
UMAC
Q4 25
$-26.7M
$-9.8M
Q3 25
$-24.2M
$-7.5M
Q2 25
$-20.2M
$-2.7M
Q1 25
$-22.0M
$-1.2M
Q4 24
$-18.3M
$-1.3M
Q3 24
$-21.6M
$-536.7K
Q2 24
$-21.5M
$-986.2K
Q1 24
$-19.8M
$-1.2M
Free Cash Flow
TSHA
TSHA
UMAC
UMAC
Q4 25
Q3 25
$-24.3M
$-8.8M
Q2 25
Q1 25
Q4 24
$-18.3M
Q3 24
$-21.6M
Q2 24
$-21.7M
Q1 24
$-19.9M
FCF Margin
TSHA
TSHA
UMAC
UMAC
Q4 25
Q3 25
-413.2%
Q2 25
Q1 25
Q4 24
-905.5%
Q3 24
-1210.9%
Q2 24
-1951.9%
Q1 24
-584.5%
Capex Intensity
TSHA
TSHA
UMAC
UMAC
Q4 25
Q3 25
60.3%
Q2 25
Q1 25
Q4 24
0.1%
Q3 24
2.0%
0.0%
Q2 24
18.1%
Q1 24
4.1%
Cash Conversion
TSHA
TSHA
UMAC
UMAC
Q4 25
Q3 25
-4.70×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TSHA
TSHA

Segment breakdown not available.

UMAC
UMAC

Retail Revenue$4.5M92%
Other$412.7K8%

Related Comparisons